COVID-19 Severity is Associated with Immunopathology and Multi-Organ Damage

Yan-Mei Chen,Yuanting Zheng,Ying Yu,Yunzhi Wang,Qingxia Huang,Feng Qian,Lei Sun,Zhi-Gang Song,Ziyin Chen,Jinwen Feng,Yanpeng An,Jingcheng Yang,Zhenqiang Su,Shanyue Sun,Fahui Dai,Qinsheng Chen,Qinwei Lu,Pengcheng Li,Yun Ling,Zhong Yang,Huiru Tang,Leming Shi,Li Jin,Edward C. Holmes,Chen Ding,Tong-Yu Zhu,Yong-Zhen Zhang
DOI: https://doi.org/10.1101/2020.06.19.20134379
2020-01-01
Abstract:AbstractCOVID-19 is characterised by dysregulated immune responses, metabolic dysfunction and adverse effects on the function of multiple organs. To understand how host responses contribute to COVID-19 pathophysiology, we used a multi-omics approach to identify molecular markers in peripheral blood and plasma samples that distinguish COVID-19 patients experiencing a range of disease severities. A large number of expressed genes, proteins, metabolites and extracellular RNAs (exRNAs) were identified that exhibited strong associations with various clinical parameters. Multiple sets of tissue-specific proteins and exRNAs varied significantly in both mild and severe patients, indicative of multi-organ damage. The continuous activation of IFN-I signalling and neutrophils, as well as a high level of inflammatory cytokines, were observed in severe disease patients. In contrast, COVID-19 in mild patients was characterised by robust T cell responses. Finally, we show that some of expressed genes, proteins and exRNAs can be used as biomarkers to predict the clinical outcomes of SARS-CoV-2 infection. These data refine our understanding of the pathophysiology and clinical progress of COVID-19 and will help guide future studies in this area.
What problem does this paper attempt to address?